ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

VINC Vincerx Inc

0.8768
-0.0532 (-5.72%)
May 03 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 310,181
Bid Price 0.60
Ask Price 1.85
News -
Day High 0.935

Low
0.61

52 Week Range

High
9.3722

Day Low 0.8511
Share Name Share Symbol Market Stock Type
Vincerx Inc VINC NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.0532 -5.72% 0.8768 23:00:07
Open Price Low Price High Price Close Price Previous Close
0.9272 0.8511 0.935 0.8771 0.93
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
1,078 310,181 US$ 0.8936821 US$ 277,203 - 0.61 - 9.3722
Last Trade Type Quantity Price Currency
18:55:57 25 US$ 0.8764 USD

Vincerx Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
406.23M 21.38M - 0 -40.16M -1.88 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Vincerx News

Date Time Source News Article
4/25/202423:27GlobeNewswire Inc.Vincerx Pharma Announces Pricing of Underwritten Public..
4/25/202415:01GlobeNewswire Inc.Vincerx Pharma Announces Proposed Underwritten Public..
4/08/202415:30GlobeNewswire Inc.Vincerx Pharma Presents Positive Preliminary Phase 1 Data..
4/01/202407:00GlobeNewswire Inc.Vincerx to Host Virtual Investor Event Reviewing Preliminary..
3/29/202414:20GlobeNewswire Inc.Vincerx Pharma Reports Fourth Quarter and Full Year 2023..
3/08/202419:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/08/202419:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/05/202415:31GlobeNewswire Inc.Vincerx to Present Three Posters at the American Association..
1/16/202405:05Edgar (US Regulatory)Form 8-K - Current report
10/13/202308:12GlobeNewswire Inc.New to The Street Airs Televised Corporate Interviews..
10/06/202308:30GlobeNewswire Inc.New to The Street Announces TV Corporate Appearances,..
9/15/202315:05Edgar (US Regulatory)Form 8-K - Current report
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No VINC Message Board. Create One! See More Posts on VINC Message Board See More Message Board Posts

Historical VINC Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.790.9350.66070.7929557664,7600.086810.99%
1 Month5.926.070.66071.291,681,836-5.04-85.19%
3 Months1.359.37220.66073.061,271,115-0.4732-35.05%
6 Months0.95039.37220.612.49868,852-0.0735-7.73%
1 Year1.579.37220.612.35478,339-0.6932-44.15%
3 Years15.9118.42650.613.61246,392-15.03-94.49%
5 Years20.1226.750.614.28230,115-19.24-95.64%

Vincerx Description

Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are primarily conducted in the United States. It focuses to develop, use, manufacture, commercialize, sublicense and distribute a clinical-stage and follow-on small molecule drug program and a preclinical stage bioconjugation/next-generation ADC platform.

Your Recent History

Delayed Upgrade Clock